Assessment of Intranasal Glucagon on Endogenous Glucose Production

2016-04-17 17:16:05 | BioPortfolio

Published on BioPortfolio: 2016-04-17T17:16:05-0400

Clinical Trials [2490 Associated Clinical Trials listed on BioPortfolio]

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

The purpose of this study is to assess how glucagon administered as a puff into the nose (AMG504-1) works in children and adolescents compared with commercially-available glucagon given by...

Effect of Intranasal Anti-IgE Antibodies on IgE Production

In this study, participants will receive either intranasal anti-IgE-antibodies (n=5) or intranasal allergen (n=5) or intranasal placebo (n=5). Blood samples will be obtained before nasal a...

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

Study designed to evaluate the efficacy and safety of Intranasal (IN) Morphine Nasal Spray (MNS075) 3.75 mg, 7.5 mg, 15 mg, and 30 mg, intravenous (IV) morphine 7.5 mg, or IN placebo in pa...

Effect of Intranasal Insulin on Cognitive Processes and Appetite

This study investigates the effect of intranasal insulin on cognitive processes (behavioural and neural) in healthy lean and obese female adults. All subjects will receive a single-dose of...

Effects of Intranasal Oxytocin and Vasopressin on Social Behavior and Decision Making

The purpose of this study is to investigate the role of a one-time intranasal administration of the oxytocin, vasopressin, or placebo on prosocial decision making such as cooperation and c...

PubMed Articles [4736 Associated PubMed Articles listed on BioPortfolio]

Where is the love? A double-blind, randomized study of the effects of intranasal oxytocin on stress regulation and aggression.

Previous studies reveal that oxytocin (OT) encourages prosocial behavior in humans; however, animal studies and recent work in humans suggest that OT may also play a role in aggressive behavior and fe...

Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled Trial.

Treatment for epistaxis includes application of intranasal vasoconstrictors. These medications have a precaution against use in patients with hypertension. Given that many patients who present with ep...

Intranasal lidocaine for acute management of primary headaches: a systematic review.

Intranasal lidocaine has been studied and recommended as an alternative in the management of acute headache. The objective of this systematic review was to evaluate the efficacy and safety of intranas...

Ectopic intranasal canine tooth in a child: A rare case report and literature review.

Intranasal teeth are a rare form of ectopic teeth. Their clinical manifestation are truly variable. In children, intranasal teeth are typically associated with cleft lip and alveolus.

Distribution of insulin in trigeminal nerve and brain after intranasal administration.

In the brain, insulin acts as a growth factor, regulates energy homeostasis, and is involved in learning and memory acquisition. Many central nervous system (CNS) diseases are characterized by deficit...

Medical and Biotech [MESH] Definitions

The administration of drugs through the nasal passage.

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms.

Compounds that supress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release.

Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.

More From BioPortfolio on "Assessment of Intranasal Glucagon on Endogenous Glucose Production"

Quick Search


Searches Linking to this Trial